LAMTOR3

Across TCGA pan-cancer cohorts, LAMTOR3 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated LAMTOR3 data layer compared with 22 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LAMTOR3 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated LAMTOR3 expression acts as an unfavorable survival marker, although some lineages such as UCEC and CCRCC show a favorable association.

UCEC, CCRCC, and GBM are the cancer types where LAMTOR3 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.984	0.825	.015	8	view →
CCRCC	OS	Quartile	II,III,IV	1.000	0.812	.030	8	view →
GBM	DFS	Tertile	All	0.636	0.810	.017	7	view →
LUAD	DFS	Median	III,IV	0.409	0.941	.010	6	view →
PDAC	DFS	Median	IV	0.250	0.934	.024	3	view →
LSCC	OS	Quartile	All	0.751	0.932	.029	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

LAMTOR3–UCEC (DFS)

Open the UCEC breakdown →